| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1470-2045(16)00171-6 |
| P698 | PubMed publication ID | 27301029 |
| P2093 | author name string | Anand Shah | |
| Jason A Efstathiou | |||
| Kelsey I Ricci | |||
| P2860 | cites work | Proton versus intensity-modulated radiotherapy for prostate cancer: patterns of care and early toxicity. | Q36507549 |
| Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study | Q40938733 | ||
| Prospective preference assessment of patients' willingness to participate in a randomized controlled trial of intensity-modulated radiotherapy versus proton therapy for localized prostate cancer | Q46738659 | ||
| Impact of the year 2000 Medicare policy change on older patient enrollment to cancer clinical trials | Q50120629 | ||
| Bending the cost curve: a unique collaboration between radiation oncologists and Blue Cross Blue Shield of Massachusetts to optimize the use of advanced technology | Q50222054 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 559-561 | |
| P577 | publication date | 2016-04-27 | |
| P1433 | published in | Lancet Oncology Commission | Q13747613 |
| P1476 | title | Beyond a moonshot: insurance coverage for proton therapy. | |
| P478 | volume | 17 |
| Q38746213 | Charged-particle therapy in cancer: clinical uses and future perspectives |
| Q90028604 | Master Protocol Trial Design for Efficient and Rational Evaluation of Novel Therapeutic Oncology Devices |
| Q55384451 | Online advertising and marketing claims by providers of proton beam therapy: are they guideline-based? |
| Q45212989 | Promoting the Appropriate Use of Advanced Radiation Technologies in Oncology: Summary of a National Cancer Policy Forum Workshop. |
| Q90346232 | Proton therapy for prostate cancer: A review of the rationale, evidence, and current state |
| Q92987333 | Proton versus photon-based radiation therapy for prostate cancer: emerging evidence and considerations in the era of value-based cancer care |
| Q89474105 | Randomized Trials of Proton Therapy: Why They Are at Risk, Proposed Solutions, and Implications for Evaluating Advanced Technologies to Diagnose and Treat Cancer |
| Q56804507 | Three ways to make proton therapy affordable |